Certain Stock Options of Aurinia Pharmaceuticals Inc. are subject to a Lock-Up Agreement Ending on 21-OCT-2020. These Stock Options will be under lockup for 91 days starting from 22-JUL-2020 to 21-OCT-2020. Details: Certain of the executive officers and directors have agreed, subject to specified exceptions, not to directly or indirectly: offer, pledge, sell or contract to sell any common shares; sell any stock option or contract to purchase any common shares; purchase any stock option or contract to sell any common shares; otherwise dispose of or transfer any common shares; request or demand the company to file a registration statement related to the common shares; effect a reverse share split, recapitalization, share consolidation, reclassification or similar transaction affecting the outstanding common shares; enter into any swap or other agreement or any transaction that transfers, in whole or in part, the economic consequence of ownership of any common shares, whether any such swap, agreement or transaction is to be settled by delivery of common shares or other securities, in cash or otherwise; or publicly announce any of the foregoing. This restriction terminates after the close of trading of the common shares on and including the 90th day after the date of this prospectus supplement.